These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 28858174)

  • 1. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Yi Z; Mayorga ME; Orman ES; Wheeler SB; Hayashi PH; Barritt AS
    Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma.
    Nagai S; Kitajima T; Yeddula S; Salgia R; Schilke R; Abouljoud MS; Moonka D
    Hepatology; 2020 Dec; 72(6):2051-2062. PubMed ID: 32157711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in access to the liver transplant waiting list in the United States.
    Mathur AK; Ashby VB; Fuller DS; Zhang M; Merion RM; Leichtman A; Kalbfleisch J
    Transplantation; 2014 Jul; 98(1):94-9. PubMed ID: 24646768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
    Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
    Liver Transpl; 2018 Oct; 24(10):1346-1356. PubMed ID: 30067889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
    Mehta N; Dodge JL; Roberts JP; Yao FY
    J Hepatol; 2021 Apr; 74(4):829-837. PubMed ID: 33188904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-Based Analysis and Projections of Liver Supply Under Redistricting.
    Parikh ND; Marrero WJ; Sonnenday CJ; Lok AS; Hutton DW; Lavieri MS
    Transplantation; 2017 Sep; 101(9):2048-2055. PubMed ID: 28945663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in Waitlist and Posttransplantation Outcomes in Liver Transplant Registrants and Recipients Aged 18 to 24 Years: Analysis of the UNOS Database.
    Ebel NH; Hsu EK; Berry K; Horslen SP; Ioannou GN
    Transplantation; 2017 Jul; 101(7):1616-1627. PubMed ID: 28230640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    Brock GN; Washburn K; Marvin MR
    PLoS One; 2019; 14(10):e0223053. PubMed ID: 31581270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center.
    Tan EK; Goh BKP; Lee SY; Krishnamoorthy TL; Tan CK; Jeyaraj PR
    Transplant Proc; 2018 Dec; 50(10):3564-3570. PubMed ID: 30577239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.
    Su F; Yu L; Berry K; Liou IW; Landis CS; Rayhill SC; Reyes JD; Ioannou GN
    Gastroenterology; 2016 Feb; 150(2):441-53.e6; quiz e16. PubMed ID: 26522262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends.
    Kaur N; Emamaullee J; Lian T; Lo M; Ender P; Kahn J; Sher L
    Transplantation; 2021 May; 105(5):1052-1060. PubMed ID: 33741845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator.
    Díaz LA; Norero B; Lara B; Robles C; Elgueta S; Humeres R; Poniachik J; Silva G; Wolff R; Innocenti F; Rojas JL; Zapata R; Hunter B; Álvarez S; Cancino A; Ibarra J; Rius M; González S; Calabrán L; Pérez RM
    Ann Hepatol; 2019; 18(2):325-330. PubMed ID: 31010794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy.
    Ishaque T; Beckett J; Gentry S; Garonzik-Wang J; Karhadkar S; Lonze BE; Halazun KJ; Segev D; Massie AB
    Transplantation; 2024 Aug; 108(8):e170-e180. PubMed ID: 38548691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
    Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
    Am J Transplant; 2019 Aug; 19(8):2210-2218. PubMed ID: 30861298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.